HealthQuill USFDA
The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according to a statement from the regulator.
Drugs Health Pharma

Novavax’s vaccine targeting JN.1 strain of Covid-19 virus gets FDA approval 

The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according.

Read More
Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.
Drugs Health Pharma

Emergent gets US drug regulator’s nod to use its smallpox vaccine for mpox

Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.

Read More
The US drug regulator raised the age limit of people who want to buy tobacco products by three years to 30, and retailers must verify people buying such products, including e-cigarettes, with photo identification.
Drugs Health Pharma

US smokers need photo ID to prove new age limit set by the FDA

The US drug regulator raised the age limit of people who want to buy tobacco products by three years to 30, and retailers.

Read More
The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help find targeted therapy options.
Drugs Health Pharma

Illumina’s DNA sequencing cancer tests to check 500 genes get US nod

The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help.

Read More
The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which incorporates a new component to fight a variant of the virus.
Drugs Health Pharma

FDA approves new Covid-19 jabs before fall and winter in the United States

The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which.

Read More
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs Health Pharma

US drug regulator blocks Regeneron’s blood cancer therapy 

The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.

Read More
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal tri­al ca­pa­bil­i­ties, according to the company.
Drugs Health Pharma

Walgreens grabs $100 million from US government for decentralized trials

Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal.

Read More
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and paediatric patients.
Drugs Health Pharma

US-based ARS’s nasal spray to treat allergic reactions gets FDA nod

ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.

Read More
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.
Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data 

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.

Read More
Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare form of blood cancer that affects the skin.
Drugs Health Pharma

Citius’s blood cancer drug gets US regulatory body’s clearance 

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.

Read More